Johnson & Johnson Consumer Health business Kenvue applies to list on NYSE, filing for IPO of up to $100M under the symbol "KVUE". Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on JNJ:
- Wells Fargo upgrades Immunovant to Overweight, raises price target to $27
- Johnson & Johnson put volume heavy and directionally bearish
- Steel Dynamics to replace Abiomed in S&P 500 at open on 12/22
- Johnson & Johnson (NYSE:JNJ): This Dividend King is an Appealing Retirement Stock
- J&J announces extension of Abiomed tender offer to December 21